Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

A Comprehensive Review on Nanotechnology-Based Innovations in Topical Drug Delivery for the Treatment of Skin Cancer

Author(s): Arun Singh Lalotra, Vishesh Singh, Bharat Khurana, Shelly Agrawal, Shubham Shrestha and Daisy Arora*

Volume 26, Issue 44, 2020

Page: [5720 - 5731] Pages: 12

DOI: 10.2174/1381612826666200819202821

Price: $65

Abstract

Background: Skin is the largest organ of the body and helps to regulate several physiological functions. It acts as a barrier that protects the body against UV-radiation, toxic substances, infections, etc. The abnormal growth of the skin cells is called skin cancer. Different types of skin cancer can be classified as Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC); which mainly occur due to chronic exposure to UV- sunlight and pollution.

Methods: The conventional topical treatments of skin cancer such as cream, gel, ointment, etc., are more occlusive and thus they do not penetrate deep into the skin (dermal layer) and remain at the upper part of the skin (epidermal layer). The stratum corneum acts as a physiological barrier for the drug-loaded in the conventional formulation. The novel carrier systems have the potential to facilitate the penetration of the drug deep into the skin (dermal layer) because these have less size and higher flexibility than conventional treatment.

Conclusion: In the present review, we have discussed various novel carrier systems being investigated for the topical application of chemotherapeutic agents for efficient skin targeting and better dermatological as well as therapeutic benefits with minimal systemic exposure and toxicity.

Keywords: Skin cancer, oxidative stress, UV-B radiation, nanocarriers, topical vesicular systems, ethosomes, transethosomes.

« Previous Next »
[1]
Sobanko JF, Miller CJ, Alster TS. Topical anesthetics for dermatologic procedures: A review. Dermatol Surg 2012; 38(5): 709-21.
[http://dx.doi.org/10.1111/j.1524-4725.2011.02271.x] [PMID: 22243434]
[2]
Arora D, Nanda S. Quality by design driven development of resveratrol loaded ethosomal hydrogel for improved dermatological benefits via enhanced skin permeation and retention. Int J Pharm 2019; 567: 118448.
[http://dx.doi.org/10.1016/j.ijpharm.2019.118448] [PMID: 31226472]
[3]
Bragagni M, Mennini N, Maestrelli F, Cirri M, Mura P. Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib. Drug Deliv 2012; 19(7): 354-61.
[http://dx.doi.org/10.3109/10717544.2012.724472] [PMID: 23043648]
[4]
Garg C, Khurana P, Garg M. Molecular mechanisms of skin photoaging and plant inhibitors. Int J Green Pharm 2017; 11: 217-22.
[http://dx.doi.org/10.22377/ijgp.v11i02.1031]
[5]
Vinardell MP. Nanocarriers for Delivery of antioxidants on the skin. Cosmetics 2015; 2: 342-54.
[http://dx.doi.org/10.3390/cosmetics2040342]
[6]
Abd E, Yousef SA, Pastore MN, et al. Skin models for the testing of transdermal drugs. Clin Pharmacol 2016; 8: 163-76.
[http://dx.doi.org/10.2147/CPAA.S64788] [PMID: 27799831]
[7]
Thiele JJ, Schroeter C, Hsieh SN, Podda M, Packer L. The antioxidant network of the stratum corneum. Curr Probl Dermatol 2001; 29: 26-42.
[http://dx.doi.org/10.1159/000060651] [PMID: 11225199]
[8]
Chen J, Gao Y. Strategies for meloxicam delivery to and across the skin: A review. Drug Deliv 2016; 23(8): 3146-56.
[http://dx.doi.org/10.3109/10717544.2016.1157839] [PMID: 26956920]
[9]
Md S, Haque S, Madheswaran T, et al. Lipid based nanocarriers system for topical delivery of photosensitizers. Drug Discov Today 2017; 22(8): 1274-83.
[http://dx.doi.org/10.1016/j.drudis.2017.04.010] [PMID: 28456749]
[10]
Silpa VC Sr. a Review on Skin Cancer. Int Res J Pharm 2013; 4: 83-8.
[http://dx.doi.org/10.7897/2230-8407.04814]
[11]
Antonio JR, Antônio CR, Cardeal ILS, Ballavenuto JMA, Oliveira JR. Nanotechnology in dermatology. An Bras Dermatol 2014; 89(1): 126-36.
[http://dx.doi.org/10.1590/abd1806-4841.20142228] [PMID: 24626657]
[12]
Singh Malik D, Mital N, Kaur G. Topical drug delivery systems: A patent review. Expert Opin Ther Pat 2016; 26(2): 213-28.
[http://dx.doi.org/10.1517/13543776.2016.1131267] [PMID: 26651499]
[13]
Imokawa G, Ishida K. Biological mechanisms underlying the ultraviolet radiation-induced formation of skin wrinkling and sagging I: Reduced skin elasticity, highly associated with enhanced dermal elastase activity, triggers wrinkling and sagging. Int J Mol Sci 2015; 16(4): 7753-75.
[http://dx.doi.org/10.3390/ijms16047753] [PMID: 25856675]
[14]
Arora D, Khurana B, Nanda S. DoE directed optimization, development and evaluation of resveratrol loaded ultradeformable vesicular cream for topical antioxidant benefits. Drug Dev Ind Pharm 2020; 46(2): 227-35.
[http://dx.doi.org/10.1080/03639045.2020.1716373] [PMID: 31928244]
[15]
Das PK, Jadon S, Pradhan S, Kar DM. A review article on melanoma. J Pharm Sci Res 2016; 8: 112-7.
[16]
Kumar R, Deep G, Agarwal R. An overview of ultraviolet B radiation-induced skin cancer chemoprevention by silibinin. Curr Pharmacol Rep 2015; 1(3): 206-15.
[http://dx.doi.org/10.1007/s40495-015-0027-9] [PMID: 26097804]
[17]
Gordon R. Skin cancer: An overview of epidemiology and risk factors. Semin Oncol Nurs 2013; 29(3): 160-9.
[http://dx.doi.org/10.1016/j.soncn.2013.06.002] [PMID: 23958214]
[18]
Afaq F, Katiyar SK. Polyphenols: Skin photoprotection and inhibition of photocarcinogenesis. Mini Rev Med Chem 2011; 11(14): 1200-15.
[http://dx.doi.org/10.1007/s00403-009-1001-3.Skin] [PMID: 22070679]
[19]
Garcia-Peterson LM, Wilking-Busch MJ, Ndiaye MA, Philippe CGA, Setaluri V, Ahmad N. Sirtuins in skin and skin cancers. Skin Pharmacol Physiol 2017; 30(4): 216-24.
[http://dx.doi.org/10.1159/000477417] [PMID: 28704830]
[20]
Rodríguez S, Arenas M, Gutierrez C, et al. Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy. Clin Transl Oncol 2018; 20(4): 431-42.
[http://dx.doi.org/10.1007/s12094-017-1733-z] [PMID: 28808925]
[21]
Qidwai A, Khan S, Md S, et al. Nanostructured lipid carrier in photodynamic therapy for the treatment of basal-cell carcinoma. Drug Deliv 2016; 23(4): 1476-85.
[http://dx.doi.org/10.3109/10717544.2016.1165310] [PMID: 26978275]
[22]
Paolino D, Cosco D, Muzzalupo R, Trapasso E, Picci N, Fresta M. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharm 2008; 353(1-2): 233-42.
[http://dx.doi.org/10.1016/j.ijpharm.2007.11.037] [PMID: 18191509]
[23]
Roy P, Kalra N, Prasad S, George J, Shukla Y. Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways. Pharm Res 2009; 26(1): 211-7.
[http://dx.doi.org/10.1007/s11095-008-9723-z] [PMID: 18791811]
[24]
Gupta M, Agrawal U, Vyas SP. Nanocarrier-based topical drug delivery for the treatment of skin diseases. Expert Opin Drug Deliv 2012; 9(7): 783-804.
[http://dx.doi.org/10.1517/17425247.2012.686490] [PMID: 22559240]
[25]
Verma S, Utreja P. Vesicular nanocarrier based treatment of skin fungal infections: Potential and emerging trends in nanoscale pharmacotherapy. Asian J Pharm Sci 2019; 14(2): 117-29.
[http://dx.doi.org/10.1016/j.ajps.2018.05.007] [PMID: 32104444]
[26]
Khurana B, Goyal AK, Budhiraja A, Aora D, Vyas SP. Lipoplexes versus nanoparticles: pDNA/siRNA delivery. Drug Deliv 2013; 20(2): 57-64.
[http://dx.doi.org/10.3109/10717544.2012.752419] [PMID: 23537464]
[27]
Caddeo C, Nacher A, Vassallo A, et al. Effect of quercetin and resveratrol co-incorporated in liposomes against inflammatory/oxidative response associated with skin cancer. Int J Pharm 2016; 513(1-2): 153-63.
[http://dx.doi.org/10.1016/j.ijpharm.2016.09.014] [PMID: 27609664]
[28]
Arora D, Goyal AK, Paliwal SR, Khurana B, Vyas SP. Oral mucosal immunization: Recent advancement and future prospects. Curr Immunol Rev 2010; 6(3): 234-59.
[http://dx.doi.org/10.2174/157339510791823637]
[29]
Yadav NK, Nanda S, Sharma G, Katare OP. Systematically optimized coenzyme q10-loaded novel proniosomal formulation for treatment of photo-induced aging in mice: Characterization, biocompatibility studies, biochemical estimations and anti-aging evaluation. J Drug Target 2016; 24(3): 257-71.
[http://dx.doi.org/10.3109/1061186X.2015.1077845] [PMID: 26302815]
[30]
Madni A, Rahim MA, Mahmood MA, et al. Enhancement of dissolution and skin permeability of Pentazocine by Proniosomes and niosomal gel. AAPS PharmSciTech 2018; 19(4): 1544-53.
[http://dx.doi.org/10.1208/s12249-018-0967-6] [PMID: 29470828]
[31]
Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes - novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties. J Control Release 2000; 65(3): 403-18.
[http://dx.doi.org/10.1016/S0168-3659(99)00222-9] [PMID: 10699298]
[32]
Paolino D, Celia C, Trapasso E, Cilurzo F, Fresta M. Paclitaxel-loaded ethosomes®: Potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses. Eur J Pharm Biopharm 2012; 81(1): 102-12.
[http://dx.doi.org/10.1016/j.ejpb.2012.02.008] [PMID: 22414731]
[33]
Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. BBA - Biomembr 1992; 226-32.
[http://dx.doi.org/10.1016/0005-2736(92)90154-E]
[34]
Avadhani KS, Manikkath J, Tiwari M, et al. Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage. Drug Deliv 2017; 24(1): 61-74.
[http://dx.doi.org/10.1080/10717544.2016.1228718] [PMID: 28155509]
[35]
Song CK, Balakrishnan P, Shim CK, Chung SJ, Chong S, Kim DD. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces 2012; 92: 299-304.
[http://dx.doi.org/10.1016/j.colsurfb.2011.12.004] [PMID: 22205066]
[36]
Abbas H, Kamel R. Potential role of resveratrol-loaded elastic sorbitan monostearate nanovesicles for the prevention of UV-induced skin damage. J Liposome Res 2019; 30(1): 45-53.
[http://dx.doi.org/10.1080/08982104.2019.1580721] [PMID: 30741053]
[37]
Sharma A, Sharma D, Baldi A, Jyoti K, Chandra R, Madan J. Imiquimod-oleic acid prodrug loaded cream reduced drug crystallinity and induced indistinguishable cytotoxicity and apoptosis in mice melanoma tumour. J Microencapsul 2019; 36(8): 759-74.
[http://dx.doi.org/10.1080/02652048.2019.1677796] [PMID: 31587598]
[38]
Ekambaram P. Solid lipid nanoparticles. Sci Rev Commun 2011; 2(1): 80-102.
[39]
Ramteke KH, Joshi SA, Dhole SN. Solid lipid nanoparticle. A review. IOSR J Pharm 2012; 2: 34-44.
[40]
Bagul SU, Pisal VV, Solanki VN, Karnavat A. Current status of solid lipid nanoparticles: A review. Mod Appl Bioequivalence Bioavailab 2018; 3: 1-9.
[41]
Surender V, Deepika M. Solid lipid nanoparticles: A comprehensive review. J Chem Pharm Res 2016; 8(8): 102-14.
[42]
Khallaf RA, Salem HF, Abdelbary A. 5-Fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment. Drug Deliv 2016; 23(9): 3452-60.
[http://dx.doi.org/10.1080/10717544.2016.1194498] [PMID: 27240935]
[43]
Khosa A, Reddi S, Saha RN. Nanostructured lipid carriers for site-specific drug delivery. Biomed Pharmacother 2018; 103: 598-613.
[http://dx.doi.org/10.1016/j.biopha.2018.04.055] [PMID: 29677547]
[44]
Li Q, Cai T, Huang Y, Xia X, Cole SPC, Cai Y. A review of the structure, preparation, and application of NLCs, PNPs, and PLNs. Nanomaterials (Basel) 2017; 7(6): 1-25.
[http://dx.doi.org/10.3390/nano7060122] [PMID: 28554993]
[45]
Iqbal B, Ali J, Ganguli M, Mishra S, Baboota S. Silymarin-loaded nanostructured lipid carrier gel for the treatment of skin cancer. Nanomedicine (Lond) 2019; 14(9): 1077-93.
[http://dx.doi.org/10.2217/nnm-2018-0235] [PMID: 31050580]
[46]
Madhav S, Gupta D. A review on microemulsion based system. Int J Pharm Sci Res 2011; 2: 1888-99.
[47]
Khurana B, Arora D, Narang R. Topical delivery of nanoemulsion for antipsoriatic drugs. J Drug Deliv Ther 2018; 8: 1-11.
[http://dx.doi.org/10.22270/jddt.v8i5-s.1914]
[48]
Intagliata S, Modica MN, Santagati LM, Montenegro L. Strategies to improve resveratrol systemic and topical bioavailability: An update. Antioxidants 2019; 8(8): E244.
[http://dx.doi.org/10.3390/antiox8080244] [PMID: 31349656]
[49]
Bhattacharya R, Mukhopadhyay S. Review on microemulsion- as a potential novel drug delivery system. World J Pharm Pharm Sci 2016; 5: 700-29.
[50]
Khurana B, Arora D, Narang RK. FbD supported development and in vitro evaluation of Carbomer based Resveratrol loaded Topical Antipsoriatic Nanoemulgel for its targeted skin delivery. Pharm Nanotechnol 2020; 8(2): 91-107.
[http://dx.doi.org/10.2174/2211738508666200129160027] [PMID: 31995028]
[51]
Jaiswal M, Dudhe R, Sharma PK. Nanoemulsion: An advanced mode of drug delivery system. 3 Biotech 2015; 5(2): 123-7.
[http://dx.doi.org/10.1007/s13205-014-0214-0] [PMID: 28324579]
[52]
Nikam TH, Patil MP, Patil SS, Vadnere GP, Lodhi S. Nanoemulsion: A brief review on development and application in Parenteral Drug Delivery. Adv Pharm J 2018; 3: 43-54.
[http://dx.doi.org/10.31024/apj.2018.3.2.2]
[53]
Ma H, Yu M, Lei M, Tan F, Li N. A novel topical targeting system of caffeine microemulsion for inhibiting UVB-induced skin tumor: Characterization, optimization, and evaluation. AAPS PharmSciTech 2015; 16(4): 905-13.
[http://dx.doi.org/10.1208/s12249-014-0278-5] [PMID: 25591953]
[54]
Dalmolin LF, Lopez RFV. Nanoemulsion as a platform for iontophoretic delivery of lipophilic drugs in skin tumors. Pharmaceutics 2018; 10(4): 1-18.
[http://dx.doi.org/10.3390/pharmaceutics10040214] [PMID: 30400343]
[55]
Krishnasailaja A, Siddidua A, Gupta P. An overall review on polymeric nanoparticles. Int J Res Pharm Pharm Sci 2017; 2: 21-8.
[56]
Nagavarma BVN, Yadav HKS, Ayaz A, Vasudha LS, Shivakumar HG. Different techniques for preparation ofpolymeric nanoparticles-A. Asian J Pharm Clin Res 2012; 5(3): 16-23.
[57]
Jawahar N, Meyyanathan S. Polymeric nanoparticles for drug delivery and targeting: A comprehensive review. Int J Health Allied Sci 2012; 1: 217.
[http://dx.doi.org/10.4103/2278-344X.107832]
[58]
Chen Z, Zhang L, Song Y, et al. Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery. Biomaterials 2015; 52: 240-50.
[http://dx.doi.org/10.1016/j.biomaterials.2015.02.001] [PMID: 25818430]
[59]
Huang G, Liu Y, Chen L. Chitosan and its derivatives as vehicles for drug delivery. Drug Deliv 2017; 24(sup1): 108-3.
[http://dx.doi.org/10.1080/10717544.2017.1399305] [PMID: 29124981]
[60]
Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res 1998; 15(9): 1326-31.
[http://dx.doi.org/10.1023/A:1011929016601] [PMID: 9755881]
[61]
Ahmed TA, Aljaeid BM. Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery. Drug Des Devel Ther 2016; 10: 483-507.
[http://dx.doi.org/10.2147/DDDT.S99651] [PMID: 26869768]
[62]
Nan W, Ding L, Chen H, et al. Topical use of quercetin-loaded chitosan nanoparticles against ultraviolet B radiation. Front Pharmacol 2018; 9: 826.
[http://dx.doi.org/10.3389/fphar.2018.00826] [PMID: 30140227]
[63]
Shahzad A, Khan A, Afzal Z, et al. Composite HPMC and sodium alginate based buccal formulations for nicotine replacement therapy. Int J Biol Macromol 2018; 91: 31-44.
[64]
Okeke OC, Boateng JS. Composite HPMC and sodium alginate based buccal formulations for nicotine replacement therapy. Int J Biol Macromol 2016; 91: 31-44.
[http://dx.doi.org/10.1016/j.ijbiomac.2016.05.079] [PMID: 27222284]
[65]
Moradhaseli S, Mirakabadi AZ, Sarzaeem A. Nasser Mohammadpour dounighi, Saman Soheily and MRB. Preparation and characterization of sodium alginate nanoparticles containing ICD-85 (Venom Derived Peptides). Int J Innov Appl Stud 2013; 4: 534-42.
[66]
Yasmin R, Shah M, Khan SA, Ali R. Gelatin nanoparticles: A potential candidate for medical applications. Nanotechnol Rev 2017; 6: 191-207.
[http://dx.doi.org/10.1515/ntrev-2016-0009]
[67]
Singh K, Mishra A. Gelatin nanoparticle: Preparation, characterization and application in drug delivery. Int J Pharm Sci Res 2014; 5: 2149-57.
[http://dx.doi.org/10.13040/IJPSR.0975-8232.5(6).2149-57]
[68]
Elzoghby AO. Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research. J Control Release 2013; 172(3): 1075-91.
[http://dx.doi.org/10.1016/j.jconrel.2013.09.019] [PMID: 24096021]
[69]
Dragicevic-Curic N, Fahr A. Liposomes in topical photodynamic therapy. Expert Opin Drug Deliv 2012; 9(8): 1015-32.
[http://dx.doi.org/10.1517/17425247.2012.697894] [PMID: 22731896]
[70]
Pizzimenti S, Dianzani C, Zara GP, et al. Challenges and opportunities of nanoparticle-based theranostics in skin cancer Nanosci Dermatology. 2016; pp. pp. 177-88.
[http://dx.doi.org/10.1016/B978-0-12-802926-8.00014-8]
[71]
Ganesan P, Choi DK. Current application of phytocompound-based nanocosmeceuticals for beauty and skin therapy. Int J Nanomedicine 2016; 11: 1987-2007.
[http://dx.doi.org/10.2147/IJN.S104701] [PMID: 27274231]

Rights & Permissions Print Cite
Article Metrics
20
© 2024 Bentham Science Publishers | Privacy Policy